(Q30998003)

28 June 2017

1 reference

title

Techniques to assess the proliferative potential of brain tumors (English)

1 reference

Alfredo Quińones- Hinojosa

28 June 2017

1 reference

series ordinal

1

object named as

Alfredo Quiñones-Hinojosa

1 reference

28 June 2017

Nader Sanai

2

1 reference

28 June 2017

Justin S Smith

series ordinal

3

1 reference

28 June 2017

Michael W McDermott

series ordinal

4

1 reference

28 June 2017

publication date

1 August 2005

1 reference

Journal of Neuro-Oncology

28 June 2017

published in

1 reference

28 June 2017

volume

74

1 reference

28 June 2017

issue

1

1 reference

28 June 2017

page(s)

19-30

1 reference

Correlation of DNA content and histology in prognosis of astrocytomas

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-004-5758-0

Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-004-5758-0

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-004-5758-0

Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-004-5758-0

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-004-5758-0

Hepatitis C virus, antibodies, and infectivity. Paradox, pragmatism, and policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-004-5758-0

Human brain tumors: assessment with in vivo proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-004-5758-0

Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-004-5758-0

Nucleolar organizer regions in hepatocarcinogenesis induced by N-2-fluorenylacetamide in rats: comparison with bromodeoxyuridine immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-004-5758-0

MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p

21 January 2018

1 reference

12 December 2020

Functions of the MDM2 oncoprotein

1 reference

12 December 2020

Controlled silver-staining of nucleolus organizer regions with a protective colloidal developer: a 1-step method

1 reference

12 December 2020

Prognostic implications of the proliferative potential of low-grade astrocytomas

1 reference

12 December 2020

Clinical application of morphologic and immunocytochemical assessments of cell proliferation

1 reference

12 December 2020

The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology

1 reference

12 December 2020

Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling

1 reference

12 December 2020

The retinoblastoma gene is involved in malignant progression of astrocytomas

1 reference

12 December 2020

Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival.

1 reference

12 December 2020

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

1 reference

12 December 2020

Correlation between bromodeoxyuridine-labeling indices and patient prognosis in cerebral astrocytic tumors of adults

1 reference

12 December 2020

Glucose and methionine uptake and proliferative activity in meningiomas

1 reference

12 December 2020

Viruses and the cell cycle

1 reference

12 December 2020

Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence

1 reference

12 December 2020

Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling

1 reference

12 December 2020

Prediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labeling.

1 reference

12 December 2020

Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.

1 reference

12 December 2020

CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

1 reference

12 December 2020

Oligodendroglioma. Histologic evaluation and prognosis.

1 reference

12 December 2020

Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications

1 reference

12 December 2020

Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry

1 reference

12 December 2020

Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.

1 reference

12 December 2020

Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: A comparative study

1 reference

12 December 2020

TI-201 SPECT compared with histopathologic grade in the prognostic assessment of cerebral gliomas.

1 reference

12 December 2020

MIB-1 proliferation index predicts survival among patients with grade II astrocytoma

1 reference

12 December 2020

Flow cytometric analysis of cellular DNA content in human astrocytomas and oligodendrogliomas

1 reference

12 December 2020

Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy

1 reference

12 December 2020

Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences

1 reference

12 December 2020

Study of the DNA content by flow cytometry and proliferation in 281 brain tumors.

1 reference

12 December 2020

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype

1 reference

12 December 2020

Prognostic significance of nuclear DNA content in human neuroepithelial tumors

1 reference

12 December 2020

Proliferative potential of human brain tumours as assessed by nucleolar organizer regions (AgNORs) and Ki67-immunoreactivity

1 reference

12 December 2020

Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta

1 reference

12 December 2020

Proliferating cell nuclear antigen (PCNA) in low-grade astrocytomas: its prognostic significance

1 reference

12 December 2020

The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up

1 reference

12 December 2020

Detection of proliferating cell nuclear antigen in gliomas and adjacent resection margins.

1 reference

12 December 2020

A commentary on the biology and growth kinetics of low-grade and high-grade gliomas

1 reference

12 December 2020

Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme

1 reference

12 December 2020

Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene

1 reference

12 December 2020

Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens

1 reference

12 December 2020

Histological grading, DNA content, cell proliferation and survival of patients with astroglial tumors.

1 reference

12 December 2020

Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study.

1 reference

12 December 2020

Silver colloid staining technique for analysis of glioma malignancy

1 reference

12 December 2020

Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendrogliomas

1 reference

12 December 2020

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

12 December 2020

Meningioma: proliferating potential and clinicoradiological features.

1 reference

12 December 2020

Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives

1 reference

12 December 2020

TP53 Gene Mutations and 17p Deletions in Human Astrocytomas

1 reference

12 December 2020

Value of AgNOR method in predicting recurrence of meningioma

1 reference

12 December 2020

Comparison of three quantitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms

1 reference

12 December 2020

S-phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine

1 reference

12 December 2020

Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities

1 reference

12 December 2020

Growth rate of intracranial meningioma: tumor doubling time and proliferating cell nuclear antigen staining index

1 reference

12 December 2020

Checking on the cell cycle

1 reference

12 December 2020

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

1 reference

12 December 2020

Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients

1 reference

12 December 2020

Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool

1 reference

12 December 2020

Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.

1 reference

12 December 2020

Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples

1 reference

12 December 2020

Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.

1 reference

12 December 2020

Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiforme.

1 reference

12 December 2020

Relationship between proliferative activity and ploidy level in a series of 530 human brain tumors, including astrocytomas, meningiomas, schwannomas, and metastases

1 reference

12 December 2020

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

12 December 2020

Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography.

1 reference

12 December 2020

The application of 5-bromodeoxyuridine in the management of CNS tumors

1 reference

12 December 2020

Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines

1 reference

12 December 2020

Biologic parameters that correlate with the prognosis of human gliomas.

1 reference

12 December 2020

Clinical evaluation of DNA index in human brain tumors

1 reference

12 December 2020

Diagnosis of cerebral metastases by thallium 201

1 reference

12 December 2020

A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma

1 reference

12 December 2020

Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues

1 reference

12 December 2020

Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human astrocytomas

1 reference

12 December 2020

CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.

1 reference

12 December 2020

Prognostic factors in gliomas. A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers

1 reference

12 December 2020

Proliferative potential and prognostic evaluation of low-grade astrocytomas

1 reference

12 December 2020

Rapid detection of proliferating potential in human brain tumors by nucleolar organizer region staining on squash preparations

1 reference

12 December 2020

Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.

1 reference

12 December 2020

Nucleolar organizer regions in various human brain tumors

1 reference

12 December 2020

MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors

1 reference

12 December 2020

Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization.

1 reference

12 December 2020

Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms

1 reference

12 December 2020

99Tcm-HMPAO brain SPECT in the evaluation of prognosis after surgical resection of astrocytoma. Comparison with other noninvasive imaging techniques (CT, MRI and 201Tl SPECT)

1 reference

12 December 2020

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

1 reference

12 December 2020

Prognostic implications of the bromodeoxyuridine labeling index of human gliomas

1 reference

12 December 2020

What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?

1 reference

12 December 2020

Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value.

1 reference

12 December 2020

The prognostic significance of Ki-67 labeling indices for oligodendrogliomas

1 reference

12 December 2020

Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma

1 reference

12 December 2020

Proliferating cell nuclear antigen is required for DNA excision repair

1 reference

12 December 2020

Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens

1 reference

12 December 2020

Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma

1 reference

12 December 2020

Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas

1 reference

12 December 2020

Clinical and biological significance of aneuploidy in human tumours

1 reference

12 December 2020

Proportion of S-phase tumor cells measured by flow cytometry is an independent prognostic factor in meningioma tumors

1 reference

12 December 2020

Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase

1 reference

12 December 2020

Ki-67 (clone MIB-1) proliferation index in recurrent glial neoplasms: no prognostic significance

1 reference

12 December 2020

Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine

1 reference

12 December 2020

Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis

1 reference

12 December 2020

Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases.

1 reference

12 December 2020

A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters

1 reference

12 December 2020

Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.

1 reference

12 December 2020

Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine

1 reference

12 December 2020

Deletion of p16 and p15 genes in brain tumors

1 reference

12 December 2020

Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.

1 reference

12 December 2020

Grading of oligodendrogliomas

1 reference

12 December 2020

Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence.

1 reference

12 December 2020

Proliferative activity in craniopharyngiomas: clinicopathological correlations in adults and children.

1 reference

12 December 2020

10.1007/S11060-004-5758-0

Identifiers

DOI

1 reference

Dimensions Publication ID

28 June 2017

1016239844

0 references

1 reference